23 July 2021

GSK Stockmann contributed to the publication of the IFLR ESG report

The IFLR ESG report has been published by the International Financial Law Review (IFLR), a market-leading financial law publication for in-house counsel and law firms specializing in financial law.

Luxembourg continues to be the leading hub for the establishment of investment funds in Europe. Despite the COVID-19 pandemic, Luxembourg has seen a  continued growth of the assets under management (AUM), increasing to the staggering amount of €5,248.971 billion as at the end of March 2021, which shows a continuous and stable growth and development in the market. One of the current trends driving growth and development in the Luxembourg fund industry is sustainable finance.

GSK Stockmann contributed to the report: Dr. Marcel Bartnik (Local Partner at GSK Stockmann in Luxembourg) and Irina Stoliarova (Senior Associate at GSK Stockmann in Luxembourg) composed the article “ESG drives growth within Luxembourg’s investment funds industry” discussing Luxembourg’s fund industry including the trends driving its growth and the hurdles to overcome.

The article is available for download as a PDF file and free to access on the IFLR website.

Print


Press contact
Beate Dünschede
+352 271802-29
beate.duenschede@gsk-lux.com

Back

GSK Updates
  • 03.08.2021

    GSK Update: Cross-Border Distribution Directive implemented – What you should know

    Read more
  • 07.05.2021

    GSK Update: Introducing the new sustainable finance measures of the EU Commission

    Read more
  • 30.03.2021

    GSK Update: SFDR – new RTS – What you should know

    Read more
Contact person

Dr. Marcel Bartnik

Local Partner

+352 271802-80

marcel.bartnik@gsk-lux.com

Irina Stoliarova, LL.M.

Senior Associate

+352 271802-52

irina.stoliarova@gsk-lux.com

© GSK Stockmann 2021